Lung Cancer In Men: Everything You Need To Know
Owing to the immense importance of your lungs, it is safe to say that your life depends on them. Lungs are integral organs of your respiratory system and help you breathe. Even a minor issue with your lungs should be taken seriously.
Lung cancer is a serious health complication affecting many males worldwide every year. Being more prone to smoking, men become easy victims of lung cancer, putting their lives at risk. Lung cancer is one of the most common types of cancer and can be fatal if not treated on time. If you or any of your loved ones experience lung-related issues, make sure you seek immediate medical care.
What Is Lung Cancer?
Lung cancer is cancer that develops in the tissue of your lungs. Most lung cancers start in the small air sacs or bronchi, spreading to other vital organs. Patients suffering from the problem need immediate Lung cancer treatment to stop cancer from spreading.
Lung cancer is a result of uncontrolled cell division in your lungs. While cell division is necessary to lead a healthy life, there is a limit to which your cells should divide. Mutations in your cells lead to uncontrolled cell division. When damaged cells multiply, they result in tumors that may spread to other parts of your body. When these tumors spread, they hamper your body's functionality, leading to dire implications.
Lung cancer may stay within your lungs or spread to other organs, making matters worse. If you fall victim to lung cancer, make sure you get treated by the best doctor in your city. For instance, if you are a Gurgaon resident, seek the best lung cancer treatment in Gurgaon without any delay.
Types Of Lung Cancer
Depending on the size of the cells dividing uncontrollably, there are two major types of lung cancer – non-small cell lung cancer and small cell lung cancer.
Non-small Cell Lung Cancer
This is the most common lung cancer type, affecting men all over the world. Non-small lung cancer includes multiple cancer types, including:
• Adenocarcinoma
• Squamous cell carcinoma
• Sarcomatoid carcinoma
• Adenosquamous carcinoma
Small Cell Lung Cancer
While this is not a common lung cancer type, small cell lung cancer is more difficult to treat as compared to non-small cell lung cancer. It grows more quickly, making cancer treatment tough. In most cases, the cancer is found in the form of a small tumor that has already spread to the patient’s other body parts. Common small-cell lung cancer types include small-cell carcinoma and combined small-cell carcinoma.
Other Lung Cancer Types
Apart from the two types discussed above, your lung can also become a target of other cancerous tumors arising within or outside your lungs. Some of these cancers include:
• Lymphoma – Cancer in your lymph nodes
• Pleural Mesothelioma – Cancer in your lungs’ lining
• Sarcoma – Cancer in your soft tissue or bones
Note that the cancer treatment for these cases differs from conventional lung cancer treatments.
Different Lung Cancer Stages
The different lung cancer stages are determined by the initial tumor’s size, how deep/far the tumor goes in the surrounding tissues and its spread to other organs close to the lungs.
Here is a glimpse of the generalized staging of lung cancer:
• Stage 0 – Also called in-situ, this is the stage when the cancer is still in the top lining of your lung. It still has not spread to other parts of your lung.
• Stage 1 – This is the stage where cancer has started spreading inside your lung but hasn’t spread outside of the organ.
• Stage 2 – This is the stage where cancer has become larger. Here, there may be more than one tumor in a single lobe of the lung, or cancer may have spread to the lymph nodes.
• Stage 3 – At this stage, cancer has spread to the lymph nodes near your lungs. This is also the stage where you may have more than one tumor in multiple lobes of the same lung.
• Stage 4 – This is the last lung cancer stage, where the tumor has spread to the second lung, the fluid around your heart, the fluid around your lungs, or other vital organs of your body.
The Difference Between Limited And Extensive Stage
Along with the stages discussed above, lung cancer is also described as being in a limited or extensive stage.
Limited-stage lung cancer is a condition where the tumor is limited to a single lung. Even if it has spread to the lymph nodes, the tumor remains on the same side of the lung.
On the other hand, extensive lung cancer is a condition where the tumor either spreads throughout one lung or reaches the other lung. This is also the stage where the tumor may spread to other parts of your body.
Metastatic Lung Cancer
Metastasis is a common term used for lung cancer cases. Simply put, metastatic lung cancer is the cancer that originates in one lung but spreads to the other lung (and/or the surrounding organs). Naturally, the cancer treatment for metastatic cancer is tougher than tackling a tumor that hasn’t spread much.
Major Symptoms Of Lung Cancer In Men
Some of the major lung cancer symptoms in men include:
• Developing a cough that doesn’t go away (or worsens over time)
• Shortness of breath
• Pain or discomfort in the chest
• A wheezing sound while breathing
• Coughing up blood
• A hoarse voice
• Loss of appetite
• Unexplained tiredness
• Unexplained weight loss
• Shoulder ache
• Swelling in the face, neck, upper chest, or arms
• Drooping eyelid in one eye
Understanding The First Signs Of Lung Cancer In Men
Chronic pneumonia or a cough that keeps returning are some of the most common early signs of lung cancer. Patients often discard these symptoms as something trivial until the complications get worse.
If you start experiencing symptoms like chest pain, shortness of breath, worsening cough, or unexplained weight loss, make sure you seek an oncologist in your city. If you are a Delhi resident, look for the best onco surgeon in Delhi for a thorough diagnosis.
Diagnosis Of Lung Cancer
If you feel even minor symptoms of lung cancer, make sure you visit your doctor for a comprehensive diagnosis. When you approach your doctor for the first time, they will ask you about your symptoms and their severity. They will also ask you about your medical history before recommending diagnostic tests.
Based on the initial assessment and physical examination, your doctor will recommend a screening test, such as an X-ray or a blood test. This will help the doctor confirm that you are facing lung cancer and nothing else.
If your doctor feels you may be suffering from lung cancer, they would further recommend imaging tests, such as a CT scan followed by a biopsy. You may also be asked to get a PET/CT scan done to see if cancer has spread to other organs.
Treatment Of Lung Cancer
All the diagnostic tests recommended by your doctor will help them confirm the presence of lung cancer. Depending on the stage of cancer, they will recommend suitable treatment procedures for your health complication.
Here are the different lung cancer treatment procedures used by oncologists to tackle your cancer:
Surgery
Surgery is a cancer treatment procedure ideal for cases wherein the cancer hasn’t spread enough. Here, the surgeon will remove your tumor and a small portion of the surrounding healthy tissue to prevent the cancer from spreading.
Radiofrequency Ablation
Radiofrequency ablation is often used to treat tumors present near the outer edges of the lungs. Here, medical professionals use high-energy radio waves to heat and destroy the cancerous cells.
Radiation Therapy
Radiation therapy is used by doctors to shrink tumors and relieve the patient from pain. Here, doctors use high-energy beams to kill the tumor or reduce its size. In many cases, radiation therapy is used to make surgery more effective.
Chemotherapy
Chemotherapy is often recommended to treat cancers in the later stages. It is a combination of several medications used to prevent cancer from spreading. Doctors may use chemotherapy before or after surgery to ensure better cancer treatment. Chemotherapy can also be used along with other procedures, such as immunotherapy.
Immunotherapy
It is common for our bodies to recognize damaged or harmful cells, promoting them to destroy them. Lung cancer often hides from the immune system, preventing its destruction. Through immunotherapy, doctors expose your lung cancer to your immune system, prompting it to fight the disease.
The Final Word
These were some of the most important aspects to consider regarding lung cancer in men. If you or anyone in your family experience any of the symptoms discussed above, seek immediate medical help to prevent the matter from getting worse. To tackle it effectively, it is important to understand how serious lung cancer is. Reach out to an experienced oncologist who is in tune with the latest technology while treating lung cancer.
18+ Yrs Exp | 5,700+ Thoracic & Robotic Cancer Surgeries
Dr. Parveen Yadav is a Director and Senior Consultant in Thoracic and Surgical Oncology, specializing in minimally invasive and robotic lung and esophageal surgeries, with advanced training from AIIMS and Tata Memorial Hospital.
View Full Profile
Lung tumors sit at the more serious end of the thoracic surgery spectrum, and for good reason. Whether a mass turns out to be benign or malignant, the window between first suspicion and confirmed diagnosis matters enormously. Miss it, or move slowly, and options narrow. Catch it early, get to the right surgeon, and the picture changes dramatically. Outcomes across the board have improved in the last decade, largely because of how much better we have gotten at finding these tumors before they declare themselves loudly. This guide walks through what patients and families actually need to understand: how doctors confirm a diagnosis, what the tests involve, and what surgical options look like depending on what the imaging and pathology reveal. Understanding Lung Tumors Not every lung tumor is cancer, though the word "tumor" understandably triggers that fear. Benign tumors, such as hamartomas or certain carcinoid tumors, grow slowly, do not invade surrounding tissue, and rarely spread anywhere. Malignant tumors are a different matter. Lung cancer is broadly split into two categories: Non-Small Cell Lung Cancer, or NSCLC, and Small Cell Lung Cancer. NSCLC makes up roughly 85% of all cases and is the type most often addressed through surgery. Understanding which type a patient has, and at what stage, shapes every decision that follows. Causes and Risk Factors The relationship between tobacco and lung cancer is so well established it barely needs restating, yet it still accounts for more than 70% of cases in India. What gets less attention is everything else. Occupational exposure to asbestos or radon gas contributes significantly in certain populations. Air pollution is no longer a minor footnote, particularly in Indian urban centers where non-smokers are presenting with lung cancer at rates that were uncommon two decades ago. Family history matters too. A first-degree relative with lung cancer raises individual risk, even without smoking history. Patients with COPD or pulmonary fibrosis also carry elevated baseline risk and often warrant screening conversations earlier than others. And passive smoking, despite being underreported, represents a real and prolonged exposure pathway for many patients. Recognizing the Symptoms The problem with early-stage lung tumors is that they often produce no symptoms at all. By the time symptoms appear, the disease may already be at an advanced stage. That is why the symptoms themselves, when they do show up, should be taken seriously rather than attributed to a lingering cold or seasonal fatigue. A cough that has lasted more than three weeks and is not resolving is worth investigating. Blood in the sputum, even a small amount, should prompt immediate evaluation. Unexplained weight loss, chest tightness that worsens with deep breathing, or progressive breathlessness over weeks or months, all of these warrant a thoracic workup. Recurrent chest infections, particularly two or more episodes of pneumonia in the same lung region, can sometimes be the first indication of an obstructing mass. Hoarseness that has appeared without an obvious cause, such as a viral illness, can reflect nerve involvement near the lung apex. None of these symptoms is diagnostic on its own. Taken together with clinical history, they provide a clear enough signal to act. Diagnosis and Evaluation: Tests Every Patient Should Know Getting to a confirmed diagnosis requires layering multiple investigations in a logical sequence. A single test rarely tells the whole story. Imaging Studies The chest X-ray remains the usual starting point in most clinical settings, though it has real limitations. It can flag an abnormality but cannot characterize it with enough precision to guide decisions. High-Resolution CT, or HRCT, is where meaningful evaluation begins. It maps the tumor precisely: size, location, relationship to the airway, proximity to vascular structures, and whether any lymph nodes appear enlarged. In most thoracic surgery centers, this is the foundational pre-operative imaging tool. PET-CT adds a metabolic dimension that HRCT alone cannot provide. It identifies whether a lesion is metabolically active, which correlates strongly with malignancy, and it detects spread to distant sites that might otherwise be missed. For staging purposes, it is essentially indispensable. MRI of the chest is not first-line but becomes relevant when there is suspected involvement of chest wall structures or major blood vessels. Tissue Diagnosis Imaging tells you where the tumor is. Tissue tells you what it is. CT-guided percutaneous needle biopsy is minimally invasive and works well for peripheral lesions that can be accessed through the chest wall without passing through major structures. For tumors involving the central airways, bronchoscopy allows direct visualization and targeted sampling, often combined with bronchoalveolar lavage or transbronchial lung biopsy depending on the location. EBUS, or endobronchial ultrasound, is a technique that deserves wider patient awareness. It allows sampling of mediastinal lymph nodes through a bronchoscopic approach, without any surgical incision. For staging, particularly in determining whether cancer has reached the nodes between the lungs, EBUS has changed what is possible without resorting to open surgery. When none of these approaches yields adequate tissue, VATS biopsy, a video-assisted thoracoscopic procedure, provides the most reliable access to lesions that are otherwise unreachable. Laboratory and Molecular Testing Pulmonary function tests measure how much lung reserve a patient has, which directly influences whether and what kind of surgery is feasible. For malignant cases, molecular profiling has become a cornerstone of treatment planning. Testing for EGFR mutations, ALK rearrangements, ROS1 fusions, and PD-L1 expression can determine whether a patient is a candidate for targeted therapy, which in some cases works better than chemotherapy with fewer side effects. Routine blood work and tumor markers round out the pre-treatment assessment. Treatment Options Treatment is never decided by a single specialist. A well-run multidisciplinary tumor board, combining the perspectives of a thoracic surgeon, medical oncologist, and radiation oncologist, evaluates each case against the full picture: tumor type, stage, the patient's overall health, lung function, and personal circumstances. For resectable tumors, surgery is still the most effective and potentially curative option. Chemotherapy is used as adjuvant treatment after surgery to lower the risk of recurrence, or as the primary treatment modality when surgery is not an option. Stereotactic Body Radiotherapy, known as SBRT, offers a non-surgical alternative for early-stage disease in patients who cannot tolerate an operation. Targeted therapies and immunotherapy have reshaped the treatment of advanced NSCLC considerably, particularly for patients with actionable mutations, where disease control is often achievable with far less systemic toxicity than traditional chemotherapy. Types of Lung Surgery Lobectomy Removing an entire lobe of the lung is the most commonly performed curative operation for NSCLC, and for good reason. Oncologically, it offers the best margins and the most thorough removal of regional lymph nodes. In early-stage disease, lobectomy is the standard against which other procedures are measured. Wedge Resection When a patient's lung function does not support removal of an entire lobe, or when a peripheral lesion is small and well-defined, a wedge resection removes a localized segment of tissue around the tumor. It preserves more lung parenchyma but comes with a slightly higher local recurrence risk compared to lobectomy, which is why patient selection matters. Segmentectomy An anatomical segmentectomy sits between lobectomy and wedge resection in both scope and risk. It removes a defined bronchopulmonary segment with its corresponding vascular and lymphatic anatomy. For selected patients with small peripheral tumors and limited pulmonary reserve, segmentectomy is increasingly recognized as an acceptable oncological approach. Pneumonectomy Removal of an entire lung is reserved for centrally located tumors where a lesser resection would leave disease behind. It carries a higher operative risk than lobectomy and demands thorough pre-operative cardiopulmonary assessment. Pneumonectomy is performed far less frequently than it was two decades ago, partly because minimally invasive techniques have expanded what is resectable through more conservative approaches. Minimally Invasive Approaches VATS, or Video-Assisted Thoracoscopic Surgery, has become the preferred approach for most resectable lung tumors in experienced thoracic centers. Using small port incisions and a thoracoscopic camera, surgeons can perform lobectomies, segmentectomies, and biopsies with outcomes that match or exceed open thoracotomy in appropriately selected patients. Robotic-Assisted Thoracic Surgery, or RATS, extends this further with three-dimensional visualization and instruments that articulate at angles no human wrist can replicate, which is particularly useful during complex dissections around the hilum. Benefits of Advanced Minimally Invasive Surgery The practical differences between VATS or robotic surgery and open thoracotomy matter greatly to patients during recovery. Post-operative pain is significantly reduced, hospital stays typically run two to four days rather than five to seven, and patients return to daily activity much faster. Wound-related complications are less common, cosmetic outcomes are considerably better, and in most cases, post-operative lung function is better preserved than after open surgery. Recovery and Post-Operative Care The recovery protocol after lung tumor surgery is structured and predictable for most patients. Hospital stay ranges from two to five days depending on the procedure and how the patient responds in the immediate post-operative period. A chest drain is placed during surgery to evacuate air and fluid; it is removed once drainage has settled, usually within a day or two of the procedure. Breathing exercises using an incentive spirometer begin within the first 24 hours. This is not optional. Keeping the alveoli inflated in the early post-operative period significantly reduces the risk of atelectasis, which is one of the more common early complications. Pain is managed through multimodal analgesia, often including epidural or paravertebral nerve blocks, which reduce dependence on opioids and allow for more comfortable movement. Patients are encouraged to walk within 24 to 48 hours of surgery. The first CT scan after surgery is typically scheduled at three months, followed by regular oncology follow-up. Patients with reduced pre-operative lung function are usually referred for pulmonary rehabilitation once they are back home. Why Expert Thoracic Care Matters Lung tumor surgery is not a procedure that tolerates mediocrity. Outcomes correlate strongly with a surgeon's case volume, the center's access to VATS and robotic platforms, and the quality of multidisciplinary coordination around each patient. The same operation, performed at a low-volume center versus a dedicated thoracic surgery unit, can produce meaningfully different results. Choosing a dedicated center ensures accurate pre-operative staging, access to minimally invasive techniques, structured post-operative care, and proper integration with oncology for adjuvant treatment planning when needed. Conclusion Everything in lung tumor management flows from the diagnosis. An accurate diagnosis, staged correctly, with tissue that has been molecularly characterized where needed, is what makes targeted treatment possible. HRCT, PET-CT, EBUS, and the range of surgical options available today have put patients in a fundamentally better position than they would have been in even 15 years ago. If you or a family member has been told that a lung mass needs evaluation, do not wait. Consult a qualified thoracic surgeon, understand your staging, and make sure the treatment plan reflects the full picture of your specific case. Early action. Expert care. Better outcomes. Book a consultation with Dr. Parveen Yadav - Thoracic Surgeon at Artemis Hospital, Gurgaon - for a specialist evaluation.
Persistent chest pain could be your heart, lungs, or a tumor. Learn the signs, red flags, and when to see a thoracic surgeon. Expert insights by Dr. Parveen Yadav.
Unexplained weight loss and fatigue may be early signs of lung cancer. Dr. Parveen Yadav explains the biology, warning signs, and when to act.
Copyright 2026 © Dr .Parveen Yadav all rights reserved.
Proudly Scaled by Public Media Solution!